Cargando…
Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme
PURPOSE: Health-related quality of life (HRQOL) in differentiated thyroid cancer (DTC) research has so far received little attention and available results are conflicting. We studied the HRQOL of radioiodine-naive DTC patients in comparison with the general population (GP), investigated the course o...
Autores principales: | Gamper, Eva-Maria, Wintner, Lisa M., Rodrigues, Margarida, Buxbaum, Sabine, Nilica, Bernhard, Singer, Susanne, Giesinger, Johannes M, Holzner, Bernhard, Virgolini, Irene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480943/ https://www.ncbi.nlm.nih.gov/pubmed/25771905 http://dx.doi.org/10.1007/s00259-015-3022-9 |
Ejemplares similares
-
Systematic review reveals lack of quality in reporting health-related quality of life in patients with gastroenteropancreatic neuroendocrine tumours
por: Martini, Caroline, et al.
Publicado: (2016) -
Correction to: do patients consider computer-adaptive measures more appropriate than static questionnaires?
por: Gamper, Eva-Maria, et al.
Publicado: (2019) -
Do patients consider computer-adaptive measures more appropriate than static questionnaires?
por: Gamper, Eva-Maria, et al.
Publicado: (2019) -
Direct comparison of (68)Ga-DOTA-TOC and (18)F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle
por: Nilica, Bernhard, et al.
Publicado: (2016) -
Long-Term Survival and Value of (18)F-FDG PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with Second Peptide Receptor Radionuclide Therapy Course with (177)Lu-DOTATATE
por: Rodrigues, Margarida, et al.
Publicado: (2021)